Breaking News, Promotions & Moves

Merck Replaces R&D Head

Perlmutter to lead global R&D efforts

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Roger M. Perlmutter, M.D., Ph.D., has been named executive vice president and president of Merck Research Laboratories (MRL), effective April 15. Dr. Perlmutter will succeed Peter S. Kim, Ph.D., who will remain with the company as an advisor until his retirement in August.   Previously, Dr. Perlmutter was executive vice president and head of R&D at Amgen from January 2001 to February 2012. During his tenure, Dr. Perlmutter oversaw the development and subsequent approval of a number of novel ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters